Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA)

Historical Holders from Q4 2020 to Q1 2025

Symbol
OLMA on Nasdaq
CUSIP
68062P106
Type / Class
Equity / Common Stock, $0.0001 par value per share
Shares outstanding
74.4M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
71.3M
Holdings value
$415M
% of all portfolios
0.002%
Grand Portfolio weight change
+0%
Number of holders
155
Number of buys
81
Number of sells
-48
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Paradigm Biocapital Advisors LP 9.99% $27.9M 7.43M Paradigm BioCapital Advisors LP Dec 31, 2024
Bain Capital Life Sciences Opportunities IV, L.P. 9.99% $26.6M 7.1M Bain Capital Life Sciences Opportunities IV, L.P. Jan 8, 2025

Institutional Holders of Olema Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (OLMA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 334K $1.25M +$122K $3.75 10
2024 Q4 71.3M $415M +$48.5M $5.83 155
2024 Q3 58.7M $700M +$12.5M $11.94 129
2024 Q2 57.9M $626M +$18.1M $10.82 127
2024 Q1 56.1M $635M +$37.7M $11.32 126
2023 Q4 51.6M $717M +$50.3M $14.03 112
2023 Q3 47.3M $584M +$135M $12.35 96
2023 Q2 36.4M $329M +$43.2M $9.03 85
2023 Q1 33.4M $116M +$1.79M $3.47 64
2022 Q4 33.3M $81.6M -$799K $2.45 65
2022 Q3 33.3M $92M -$3.94M $2.76 66
2022 Q2 34.2M $139M -$8.59M $4.07 68
2022 Q1 36.3M $155M -$17.9M $4.26 84
2021 Q4 38.4M $359M -$41.6M $9.36 91
2021 Q3 36.3M $1B -$19.8M $27.56 73
2021 Q2 37.4M $1.05B +$59M $27.98 67
2021 Q1 35.2M $1.16B -$1.71M $33.18 72
2020 Q4 34.8M $1.64B +$1.64B $48.08 55